77 related articles for article (PubMed ID: 23047502)
1. The effects of sodium ferulate on the pharmacokinetics of bupropion and its active metabolite in healthy men.
Gao LC; Huang X; Tan ZR; Fan L; Zhou HH
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1192-6. PubMed ID: 23047502
[TBL] [Abstract][Full Text] [Related]
2. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
Kim H; Bae SK; Park SJ; Shim EJ; Kim HS; Shon JH; Liu KH; Shin JG
Br J Clin Pharmacol; 2010 Jul; 70(1):126-31. PubMed ID: 20642555
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium Ferulate.
Gao L; He Y; Tang J; Yin J; Huang Z; Liu F; Ouyang D; Chen X; Zhang W; Liu Z; Zhou H
PLoS One; 2013; 8(6):e62489. PubMed ID: 23840296
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of cimetidine on the pharmacokinetics of sustained-release bupropion.
Kustra R; Corrigan B; Dunn J; Duncan B; Hsyu PH
J Clin Pharmacol; 1999 Nov; 39(11):1184-8. PubMed ID: 10579150
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
Kharasch ED; Mitchell D; Coles R
J Clin Pharmacol; 2008 Apr; 48(4):464-74. PubMed ID: 18287571
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.
Palovaara S; Pelkonen O; Uusitalo J; Lundgren S; Laine K
Clin Pharmacol Ther; 2003 Oct; 74(4):326-33. PubMed ID: 14534519
[TBL] [Abstract][Full Text] [Related]
7. Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects.
Hogeland GW; Swindells S; McNabb JC; Kashuba AD; Yee GC; Lindley CM
Clin Pharmacol Ther; 2007 Jan; 81(1):69-75. PubMed ID: 17186001
[TBL] [Abstract][Full Text] [Related]
8. Rapid clinical induction of bupropion hydroxylation by metamizole in healthy Chinese men.
Qin WJ; Zhang W; Liu ZQ; Chen XP; Tan ZR; Hu DL; Wang D; Fan L; Zhou HH
Br J Clin Pharmacol; 2012 Dec; 74(6):999-1004. PubMed ID: 22519658
[TBL] [Abstract][Full Text] [Related]
9. Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.
Lei HP; Yu XY; Xie HT; Li HH; Fan L; Dai LL; Chen Y; Zhou HH
Xenobiotica; 2010 Apr; 40(4):275-81. PubMed ID: 20102294
[TBL] [Abstract][Full Text] [Related]
10. Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
Turpeinen M; Tolonen A; Uusitalo J; Jalonen J; Pelkonen O; Laine K
Clin Pharmacol Ther; 2005 Jun; 77(6):553-9. PubMed ID: 15961986
[TBL] [Abstract][Full Text] [Related]
11. Effects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteers.
Lei HP; Ji W; Lin J; Chen H; Tan ZR; Hu DL; Liu LJ; Zhou HH
Br J Clin Pharmacol; 2009 Aug; 68(2):201-6. PubMed ID: 19694739
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective analysis of hydroxybupropion and application to drug interaction studies.
Xu H; Loboz KK; Gross AS; McLachlan AJ
Chirality; 2007 Mar; 19(3):163-70. PubMed ID: 17167747
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
15. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
18. Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation.
Fan L; Wang JC; Jiang F; Tan ZR; Chen Y; Li Q; Zhang W; Wang G; Lei HP; Hu DL; Wang D; Zhou HH
Eur J Clin Pharmacol; 2009 Apr; 65(4):403-9. PubMed ID: 19066872
[TBL] [Abstract][Full Text] [Related]
19. Effects of acetaminophen, naproxen, and acetylsalicylic acid on tapentadol pharmacokinetics: results of two randomized, open-label, crossover, drug-drug interaction studies.
Smit JW; Oh C; Rengelshausen J; Terlinden R; Ravenstijn PG; Wang SS; Upmalis D; Mangold B
Pharmacotherapy; 2010 Jan; 30(1):25-34. PubMed ID: 20030470
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate.
Mohamed MF; Minocha M; Trueman S; Feng T; Enejosa J; Fisniku O; Othman AA
Clin Pharmacol Drug Dev; 2021 Mar; 10(3):299-306. PubMed ID: 32648334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]